Salvage Stereotactic Body Radiotherapy for Patients with Prostate Cancer with Isolated Lymph Node Metastasis: A Single-Center Experience

Clinical Genitourinary Cancer

Volumn 13, Issue 4, 2015, Pages e279-e284

  Ponti, Elisabetta ^a   Ingrosso, Gianluca ^a   Carosi, Alessandra ^a   Di Murro, Luana ^a   Lancia, Andrea ^a   Pietrasanta, Franca ^a   Santoni, Riccardo ^a  

^a TOR VERGATA UNIVERSITY HOSPITAL   (Italy)

Author keywords

Lymph node metastasis; Oligometastatic state; Prostate cancer; Stereotactic radiotherapy

Indexed keywords

ANTIANDROGEN; ANTINEOPLASTIC AGENT; CHOLINE C 11; PROSTATE SPECIFIC ANTIGEN;

ACUTE TOXICITY; ADULT; AGED; ANDROGEN DEPRIVATION THERAPY; ARTICLE; BIOCHEMICAL RECURRENCE; BIOCHEMICAL RECURRENCE FREE SURVIVAL; BLOOD LEVEL; CANCER CONTROL; CANCER MORTALITY; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIARRHEA; FOLLOW UP; GASTROINTESTINAL TOXICITY; HUMAN; LINEAR ACCELERATOR; LYMPH NODE METASTASIS; MALE; MULTILEAF COLLIMATOR; OLIGOMETASTATIC PROSTATE CANCER; OVERALL SURVIVAL; PROGRESSION FREE SURVIVAL; PROSTATE CANCER; RADIATION DOSE FRACTIONATION; RADIATION INJURY; RETROSPECTIVE STUDY; SALVAGE THERAPY; STEREOTACTIC BODY RADIATION THERAPY; SURVIVAL RATE; TREATMENT OUTCOME; DRUG EFFECTS; LYMPH NODE; METABOLISM; MIDDLE AGED; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; PROCEDURES; PROSTATIC NEOPLASMS; RADIOSURGERY; TUMOR RECURRENCE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; POSITRON-EMISSION TOMOGRAPHY; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RADIOSURGERY; SALVAGE THERAPY; TREATMENT OUTCOME;

EID: 84936985149     PISSN: 15587673     EISSN: 19380682     Source Type: Journal    
DOI: 10.1016/j.clgc.2014.12.014     Document Type: Article

References (22)

1. S. Hellman, and R.R. Weichselbaum Oligometastases J Clin Oncol 13 1995 8 10
2. th ed 2008 Lippincott Williams & Wilkins Philadelphia, PA 1445 1447
3. N.L. Keating, A.J. O'Malley, and M.R. Smith Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer J Clin Oncol 24 2006 4448 4456
4. J.K. Salama, M.D. Hasselle, and S.J. Chmura Stereotactic body radiotherapy for multisite extracranial oligometastases Cancer 118 2012 2962 2970
5. A. Martin, and A. Gaya Stereotactic body radiotherapy: a review Clin Oncol 22 2010 157 172
6. J.F. Fowler The linear-quadratic formula and progress in fractionated radiotherapy Br J Radiol 62 1989 679 694
7. D.J. Brenner, A.A. Martinez, G.K. Edmundson, C. Mitchell, H.D. Thames, and E.P. Armour Direct evidence that prostate tumors show high sensitivity to fractionation (low α/β ratio), similar to late responding normal tissue Int J Radiat Oncol Biol Phys 52 2002 6 13
8. L. Feuvret, G. Noel, and J.J. Mazeron Conformity index: a review Int J Radiat Oncol Biol Phys 64 2006 333 342
9. A. van't Riet, A.C. Mak, and M.A. Moerland A conformation number to quantify the degree of conformality in brachytherapy and external beam irradiation: application to the prostate Int J Radiat Oncol Biol Phys 37 1997 731 736
10. L. Patel, A.G. Glendinning, and M.C. Kirbi Dosimetric characteristics of the Elekta Beam ModulatorTM Phys Med Biol 50 2005 5479 5492
11. M. Van Herk, J.C. de Munk, and J.V. Lebesque Automatic registration of pelvic computed tomography data and magnetic resonance scans including a full circle method for quantitative accuracy evaluation Med Phys 25 1998 2054 2067
12. J.D. Cox, J. Stetz, and T.F. Pajak Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC) Int J Radiat Oncol Biol Phys 31 1995 1341 1346
13. A.C. Tree, V.S. Khoo, and R.A. Eeles Stereotactic body radiotherapy for oligometastases Lancet Oncol 14 2013 e28 37
14. P. Berkovic, G. De Meerleer, and L. Delrue Salvage stereotactic body radiotherapy for patients with limited prostate cancer metastases: deferring androgen deprivation therapy Clin Genitourin Cancer 11 2013 27 32
15. E.E. Katz, J.N. Harding 3rd, and C. Brendler Return of serum prostate specific antigen to undetectable level following removal of solitary lymph node metastasis J Urol 168 2002 2546
16. R.S. Pruthi, J.S. Hubbard, E. Kouba, and E. Wallen Androgen-independent prostate cancer treated with resection of the solitary metastatic site Urol Int 79 2007 371 373
17. M.T. Milano, A.W. Katz, and P. Okunieff Patterns of recurrence after curative-intent radiation for oligometastases confined to one organ Am J Clin Oncol 33 2010 157 163
18. K.A. Ahmed, B.M. Barney, B.J. Davis, S.S. Park, E.D. Kwon, and K.R. Olivier Stereotactic body radiation therapy in the treatment of oligometastatic prostate cancer Front Oncol 2 2013 215
19. D.J. Brenner, M.K. Martel, and E.J. Hall Fractionated regimens for stereotactic radiotherapy of recurrent tumors in the brain Int J Radiat Oncol Biol Phys 21 1991 819 824
20. B.A. Jereczek-Fossa, G. Beltramo, and L. Fariselli Robotic image-guided stereotactic radiotherapy, for isolated recurrent primary, lymph node or metastatic prostate cancer Int J Radiat Oncol Biol Phys 82 2012 889 897
21. F. Casamassima, L. Masi, and C. Menichelli Efficacy of eradicative radiotherapy for limited nodal metastases detected with choline PET scan in prostate cancer patients Tumori 97 2011 49 55
22. P. Bonomo, S. Cipressi, and C. Saieva Clinical outcome of stereotactic body radiotherapy for abdominal lymph node metastases Tumori 99 2013 611 616